Pancreatic cancer drug trial halted over safety signals
Disease control
Terminated
This early-phase trial tested an experimental drug called SOT102 for people with advanced pancreatic cancer. Researchers wanted to see if SOT102 was safe and effective when given alone or alongside standard chemotherapy. The study was stopped early because concerning side effects…
Phase: PHASE1, PHASE2 • Sponsor: SOTIO Biotech a.s. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC